Adherence and influencing factors of high-flow nasal cannula humidified oxygen therapy in elderly patients with stable chronic obstructive pulmonary disease: A meta-analysis.

Yang Yang, Ting-Ting Liu, Dong-Mei Li, Xue-Ling Ren, Zheng Luo, Xue-Li Chen, Ying-Zhen Du, Yan-Shuang Cheng
Author Information
  1. Yang Yang: Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital, Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases, Beijing, China.
  2. Ting-Ting Liu: Department of Respiratory and Critical Care Medicine, Eight Medical Center of Chinese PLA General Hospital, Beijing, China.
  3. Dong-Mei Li: Department of Neurology, Second Medical Center of Chinese PLA General Hospital, Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases, Beijing, China.
  4. Xue-Ling Ren: Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital, Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases, Beijing, China.
  5. Zheng Luo: Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital, Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases, Beijing, China.
  6. Xue-Li Chen: Department of Respiratory and Critical Care Medicine, Second Medical Center of Chinese PLA General Hospital, Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases, Beijing, China.
  7. Ying-Zhen Du: Department of Disease Control and Prevention, Second Medical Center of Chinese PLA General Hospital, Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases, Beijing, China.
  8. Yan-Shuang Cheng: Department of Hepatobiliary and Pancreatic Surgery, First Medical Center of Chinese PLA General Hospital, Beijing, China.

Abstract

OBJECTIVE: The objective of the study was to systematically evaluate and perform a meta-analysis on the adherence to high-flow nasal cannula (HFNC) humidified oxygen therapy and its influencing factors in elderly patients with stable chronic obstructive pulmonary disease (COPD).
METHODS: Relevant literature on HFNC and COPD was retrieved from PubMed, EMbase, Web of Science, and Cochrane Library databases. Cross-sectional studies, case-control studies, and cohort studies were included. Screening and quality assessment were conducted using Endnote X9 software. Quality scores were assigned using the Newcastle-Ottawa Scale and the AHRQ assessment tool. Basic information, sample size, and adherence-related factors were extracted, and heterogeneity and publication bias were assessed.
RESULTS: A total of 321 articles were initially identified, with 8 English articles involving 325 patients included after screening. Quality assessment yielded five high-quality articles (score > 8), two medium-quality articles (score = 7), and one low-quality article (score = 6). Meta-analysis results showed a COPD patient HFNC adherence rate of 32.7%. Negative factors included the number of acute exacerbations (odds ratio [OR] =2.17), adverse reactions (OR = 4.13), regular follow-up (OR = 9.45), educational level (OR = 5.38), and concurrent medications (OR = 4.71). Positive factors included age < 70 years (OR = 0.45), duration of use (OR = 0.30), inhalation technique (OR = 0.31), treatment satisfaction (OR = 0.35), and adverse reactions (OR = 0.15). Funnel plot and Egger's test results indicated minimal publication bias.
CONCLUSION: Adherence to HFNC in elderly COPD patients is relatively low, influenced by negative factors such as the number of acute exacerbations, adverse reactions, regular follow-up, educational level, and concurrent medications. Positive factors include age < 70 years, duration of use, inhalation technique, treatment satisfaction, and adverse reactions.

Keywords

References

  1. Acute Crit Care. 2021 Nov;36(4):275-285 [PMID: 35263823]
  2. Int J Chron Obstruct Pulmon Dis. 2023 May 16;18:895-906 [PMID: 37215746]
  3. COPD. 2020 Apr;17(2):175-183 [PMID: 32183538]
  4. Respir Care. 2013 Jan;58(1):98-122 [PMID: 23271822]
  5. Clinics (Sao Paulo). 2017 Oct;72(9):562-567 [PMID: 29069260]
  6. J Intensive Care. 2015 Mar 31;3(1):15 [PMID: 25866645]
  7. Am J Transl Res. 2022 Jun 15;14(6):4074-4081 [PMID: 35836894]
  8. Sleep Breath. 2023 Jun;27(3):1049-1055 [PMID: 36057738]
  9. Trials. 2022 Dec 29;23(1):1060 [PMID: 36581995]
  10. Sleep Breath. 2022 Jun;26(2):783-791 [PMID: 34383275]
  11. Front Hum Neurosci. 2022 Jan 04;15:801918 [PMID: 35058769]
  12. Ther Adv Chronic Dis. 2020 May 13;11:2040622320920106 [PMID: 32489572]
  13. Eur J Med Res. 2021 Oct 14;26(1):122 [PMID: 34649617]
  14. World J Clin Cases. 2022 Aug 26;10(24):8615-8624 [PMID: 36157835]
  15. Int J Chron Obstruct Pulmon Dis. 2018 Apr 16;13:1195-1205 [PMID: 29713153]
  16. PLoS One. 2022 Oct 5;17(10):e0272372 [PMID: 36197917]
  17. Ann Am Thorac Soc. 2018 Apr;15(4):432-439 [PMID: 29283682]
  18. Am J Respir Crit Care Med. 2017 May 1;195(9):1207-1215 [PMID: 27997805]
  19. Eur Rev Med Pharmacol Sci. 2017 Jul;21(3 Suppl):67-72 [PMID: 28745788]
  20. J Clin Med. 2024 Mar 24;13(7): [PMID: 38610626]
  21. Respir Care. 2016 Apr;61(4):529-41 [PMID: 27016353]
  22. Eur Respir J. 2022 Apr 14;59(4): [PMID: 34649974]
  23. Trials. 2022 Jan 10;23(1):28 [PMID: 35012620]
  24. Crit Care. 2018 May 9;22(1):120 [PMID: 29743098]
  25. Heliyon. 2023 Oct 10;9(11):e20884 [PMID: 37954318]

Word Cloud

Created with Highcharts 10.0.0=ORfactorspatients0HFNCelderlyCOPDincludedarticlesadversereactionsmeta-analysishigh-flownasalcannulahumidifiedoxygentherapychronicobstructivepulmonarystudiesassessmentscoreAdherenceadherenceinfluencingstablediseaseusingQualitypublicationbias8resultsnumberacuteexacerbations4regularfollow-up45educationallevelconcurrentmedicationsPositiveage<70yearsdurationuseinhalationtechniquetreatmentsatisfactionOBJECTIVE:objectivestudysystematicallyevaluateperformMETHODS:RelevantliteratureretrievedPubMedEMbaseWebScienceCochraneLibrarydatabasesCross-sectionalcase-controlcohortScreeningqualityconductedEndnoteX9softwarescoresassignedNewcastle-OttawaScaleAHRQtoolBasicinformationsamplesizeadherence-relatedextractedheterogeneityassessedRESULTS:total321initiallyidentifiedEnglishinvolving325screeningyieldedfivehigh-quality>twomedium-quality7onelow-qualityarticle6Meta-analysisshowedpatientrate327%Negativeoddsratio[OR]=2171395387130313515FunnelplotEgger'stestindicatedminimalCONCLUSION:relativelylowinfluencednegativeincludedisease:

Similar Articles

Cited By

No available data.